Mid-Term Results of Minimally Invasive Direct Coronary Artery Bypass Grafting.
Conclusion: MIDCAB is a safe procedure with low postoperative morbidity and mortality and favorable mid-term MACCE-free survival.
PMID: 29430423 [PubMed]
Source: Korean Journal of Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Tags: Korean J Thorac Cardiovasc Surg Source Type: research
More News: Angiography | Bleeding | Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Coronary Artery Bypass Graft | CT Scan | Heart | Intensive Care | Stroke | Study | Thoracotomy